DEXAMETHASONE SUPPRESSION TEST IN THE MANAGEMENT OF HYPERANDROGENIZED PATIENTS
- 1 January 1981
- journal article
- research article
- Vol. 57 (2), 158-165
Abstract
Hyperandrogenized women [86] were evaluated with measurements of serum cortisol, dehydroepiandrosterone sulfate, testosterone, and dihydrotestosterone in pooled sera before and after a dexamethasone suppression test. According to strict criteria, 81% demonstrated a major glucocorticoid-suppressible component to their hyperandrogenism. Endocrine therapy was dictated by the results of the dexamethasone suppression test. To assess the predictive value of this test, the clinical responses of a subgroup of 55 women who received appropriate endocrine suppression therapy for 6-15 mo. were evaluated. Of this subgroup, 38 were identified as having adrenal hyperandrogenism; 3 had ovarian hyperandrogenism; and 14 had mixed hyperandrogenism. Of the 55 patients, 49 received dexamethasone alone; 3 received dexamethasone plus Ovral (an oral contraceptive containing the synthetic progestogen norgestrel 0.5 mg and ethinyl estradiol 0.05 mg); and 3, all with ovarian hyperandrogenism, received depomedroxyprogesterone acetate (Depo-Provera). Clinical response was assessed in terms of improvement or no improvement in menstrual status, acne and hirsutism. Of 29 patients with adrenal or mixed hyperandrogenism associated with abnormal menses, the menstrual status of 17 (59%) improved after dexamethasone therapy. Acne improved in 39 (100%) of 39 subjects. Hirsutism showed moderate to marked improvement in 73% after 6-15 mo. of endocrine suppression therapy. Endocrine suppression therapy, particularly with repeated low-dose dexamethasone, prescribed on the basis of a dexamethasone suppression test, is an effective means of managing hyperandrogenism.This publication has 13 references indexed in Scilit:
- Idiopathic Hirsutism — An Ovarian AbnormalityNew England Journal of Medicine, 1976
- PERIPHERAL AND OVARIAN STEROIDS IN OVARIAN HYPERTHECOSIS1976
- SERUM CORTISOL AND 11-DESOXYCORTISOL LEVELS IN HIRSUTE PREMENOPAUSAL WOMEN1976
- A New Treatment for HirsutismAnnals of Internal Medicine, 1975
- Dehydroepiandrosterone-Induced Polycystic Ovaries and Acyclicity in the RatFertility and Sterility, 1975
- ADRENAL AND OVARIAN TESTS IN FEMALE HIRSUTISMActa Endocrinologica, 1967
- Treatment of Hirsutism by Adrenal and Ovarian SuppressionJournal of Clinical Endocrinology & Metabolism, 1966
- Glucocorticoid Suppression of Urinary Testosterone Excretion in Patients with Idiopathic HirsutismJournal of Clinical Endocrinology & Metabolism, 1966
- Adrenocortical Hyperfunction in “Idiopathic” Hirsutism and the Stein-Leventhal Syndrome1JCI Insight, 1958
- FURTHER STUDIES ON THE TREATMENT OF CONGENITAL ADRENAL HYPERPLASIA WITH CORTISONE: II. THE EFFECTS OF CORTISONE ON SEXUAL AND SOMATIC DEVELOPMENT, WITH AN HYPOTHESIS CONCERNING THE MECHANISM OF FEMINIZATION*†Journal of Clinical Endocrinology & Metabolism, 1952